Navigating Novo Nordisk Board Changes: Leadersh...

By João L. Carapinha

October 21, 2025

The Novo Nordisk board changes involve a major restructuring, as the Novo Nordisk Foundation is revitalizing leadership ahead of a general meeting on November 14, 2025, where new directors will be elected. Key candidates include former CEO Lars Re...
Fabhalta Kidney Treatment Shows Promise in Slowing Disease Progression for Ig...
Keytruda Lung Cancer Treatment: Long-Term Survival Gains in NSCLC
Promising PSMA-Targeted Therapy Delays Prostate Cancer Progression
Cabotegravir HIV Prevention: First Injectable PrEP Recommended for High-Risk ...
Social Media Policy Action: Protecting Youth from Cognitive Risks
Johnson & Johnson Advances Solid Tumor Research at ESMO 2025 with Promis...
Colorectal Cancer Markers: Discovering Region-Specific Drivers for Precision ...
Tukysa Breast Cancer Therapy Boosts Progression-Free Survival in Advanced Cases
Datroway TNBC Therapy: Transforming First-Line Treatment for Metastatic Tripl...
Evolving Burden of Obesity in the US: Key Insights on Obesity Prevention Stra...
Simponi Pediatric Approval: FDA Grants First Pediatric Indication for Ulcerat...
Paving the Way for Digital Health Technologies: NICE’s Bold New Strateg...